Axcelis Technologies IncAxcelis announces a $35M investment in a new ion implantation equipment manufacturing facility in Pyeongtaek, Korea, expanding its global manufacturing capacity.

Axcelis Technologies, Inc. (Nasdaq: ACLS) announced plans to invest $35 million in a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea, as part of its global manufacturing expansion. The facility will span approximately 200,000 square feet and include warehousing, cleanrooms, and a training center, with production slated to begin in the second half of 2028. President and CEO Russell Low said the investment underscores Axcelis' commitment to supporting global semiconductor demand. The announcement follows an Investment Declaration Ceremony in Washington, D.C., with Korean trade officials, and a groundbreaking is scheduled for October 20, 2026.
Axcelis Technologies IncAxcelis announces a $35M investment in a new ion implantation equipment manufacturing facility in Pyeongtaek, Korea, expanding its global manufacturing capacity.